United Kingdom Archives

axovant parkinsons disease neuron dopamine

News and Trends 25 Oct 2018

Parkinson’s Disease Gene Therapy Clinical Trial Launched in UK

A gene therapy for Parkinson’s disease developed by Swiss biotech Axovant has been used on the first patient in a Phase I/II trial at University College London. Parkinson’s disease is a neurodegenerative disease, caused by a lack of the neurochemical dopamine in regions of the brain handling motor functions causing debilitating symptoms such as rigidity […]

October 25, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 24 Oct 2018

UK Microbiome Company Gets Financial Boost for Live Bacterial Therapy

UK-based Microbiotica has received a £4M investment from Seventure’s fund dedicated to investments in the microbiome space. With Seventure coming on board as a new investor, Microbiotica has now raised a total of £12M since its foundation in 2016. The company, a spin-out of the Sanger Institute in Cambridge, seeks to find and exploit precise […]

October 24, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 15 Oct 2018

Microsoft Signs its First Microbiome Partnership

Microsoft Genomics will work with Cambridge-based Eagle Genomics to scale up its artificial intelligence platform for microbiome research. In recent years, it has become evident that the microbes that inhabit our body are key to our health. The microbiome has been linked to conditions such as diabetes, cancer, Alzheimer’s, multiple sclerosis and many more. However, large-scale studies […]

October 15, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 11 Oct 2018

Rechargeable Dentures Could Prevent Mouth Infections

As well as helping you chew your hamburger, dentures could one day fight oral fungal infections, suggest researchers from Manchester Metropolitan University, UK. The population is getting older. In fact, it is predicted that almost half of Europe will be over 50 years old in the year 2050. Assuming that trends stay the same, this […]

October 11, 2018 - 2 minutesmins - By Jonathan Smith

More News! 10 Oct 2018

This Test Can Detect Four Drugs With Just a Fingerprint

The British company Intelligent Fingerprinting has shown that its non-invasive fingerprint drug test can yield results comparable to blood tests in just 10 minutes. The technology, developed at the University of East Anglia, can detect extremely low amounts of amphetamines, cannabis, cocaine and opiate drugs from the sweat of a single fingerprint. The sample is […]

October 10, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 9 Oct 2018

Hormone Therapy for Inherited Hormonal Disorder Fails at Phase III

A European Phase III trial has become a major stress for British biotech Diurnal. Its specially designed hormone therapy was no better than conventional therapies in treating an inherited hormonal disorder. Congenital adrenal hyperplasia is a rare genetic condition where patients lack crucial enzymes for making hormones. The most common form lacks 21-hydroxylase, the enzyme […]

October 9, 2018 - 3 minutesmins - By Jonathan Smith

Sitryx immunometabolism cancer inflammation

News and Trends 8 Oct 2018

Oxford Biotech Launches with €26M to Target ‘Immunometabolism’

Sitryx has launched today with the goal of treating cancer and inflammatory conditions by targeting the metabolism of immune cells, a promising area of research. The new company has kicked off with a €26M Series A round co-led by two specialized investors, SV Health and Sofinnova Partners. Sitryx also has investment from GSK, with […]

October 8, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

artificial pancreas blood sugar type 1 diabetes

News and Trends 3 Oct 2018

Algorithm Proves Better Than Humans at Controlling Blood Sugar in Type 1 Diabetes

A clinical trial has shown that letting an algorithm decide the amount of insulin a person with type 1 diabetes needs can help keep blood sugar levels under control. The algorithm, being developed at the University of Cambridge, is able to predict how much insulin is needed at each point in time based on the […]

October 3, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

In Depth 16 Sep 2018

Meet the Entrepreneurs Doing Biotech from Shipping Containers in London

Creative biotech startups are brewing inside a shipping container park that offers affordable research space for biologists, engineers and designers working together. The space, called Open Cell, will be opening its doors to the public this week for the London Design Festival. Chip boards made using potato waste, construction materials made with fungi and crystals […]

September 16, 2018 - 6 minutesmins - By Clara Rodríguez Fernández

Helen Tayton Martin Adaptimmune interview

Interview 11 Sep 2018

How To Break Into The Crowded Immuno-Oncology Space

The field of immuno-oncology promises to make anti-cancer treatments more effective than ever. But in this crowded field, many companies struggle to make therapies that not only are effective and safe, but that can also be scaled-up, manufactured and commercialized. Helen Tayton-Martin, Chief Business Officer at the biotech company Adaptimmune, shares her advice on how […]

September 11, 2018 - 6 minutesmins - By Clara Rodríguez Fernández

More News! 4 Sep 2018

Semi-Artificial Photosynthesis Method Produces Fuel More Efficiently Than Nature

Scientists at the University of Cambridge have developed a new photosynthesis method that combines biological and synthetic components to produce hydrogen using sunlight as the only source of energy. “Natural photosynthesis has evolved to store solar energy and to reduce the greenhouse gas carbon dioxide into sugars, but this process is not very energy […]

September 4, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 3 Sep 2018

Oxford Biotech Raises €40M to Deliver Drugs to Hard-to-Reach Targets

Evox Therapeutics has raised £35.5M (€39.4M) in a Series B fundraising that has been backed, among others, by the venture arm of Google’s parent company. A spin-out from the University of Oxford and the Karolinska Institute, Evox Therapeutics has raised a large round that will fund the development of its drug delivery technology to […]

September 3, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

United Kingdom

Parkinson’s Disease Gene Therapy Clinical Trial Launched in UK

UK Microbiome Company Gets Financial Boost for Live Bacterial Therapy

Microsoft Signs its First Microbiome Partnership

Rechargeable Dentures Could Prevent Mouth Infections

This Test Can Detect Four Drugs With Just a Fingerprint

Hormone Therapy for Inherited Hormonal Disorder Fails at Phase III

Oxford Biotech Launches with €26M to Target ‘Immunometabolism’

Algorithm Proves Better Than Humans at Controlling Blood Sugar in Type 1 Diabetes

Meet the Entrepreneurs Doing Biotech from Shipping Containers in London

How To Break Into The Crowded Immuno-Oncology Space

Semi-Artificial Photosynthesis Method Produces Fuel More Efficiently Than Nature

Oxford Biotech Raises €40M to Deliver Drugs to Hard-to-Reach Targets

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!